(Q43420485)

English

Perflubron reduces lung inflammation in respiratory syncytial virus infection by inhibiting chemokine expression and nuclear factor-kappa B activation

scientific article published in May 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 November 2017

Perflubron reduces lung inflammation in respiratory syncytial virus infection by inhibiting chemokine expression and nuclear factor-kappa B activation (English)

1 reference

Europe PubMed Central

23 November 2017

Roberto P Garofalo

5

object named as

Roberto P Garofalo

1 reference

Europe PubMed Central

23 November 2017

author name string

Helene A Haeberle

1

1 reference

Europe PubMed Central

23 November 2017

Frances Nesti

2

1 reference

Europe PubMed Central

23 November 2017

Hans-Juergen Dieterich

3

1 reference

Europe PubMed Central

23 November 2017

Zoran Gatalica

4

1 reference

Europe PubMed Central

23 November 2017

language of work or name

0 references

publication date

1 May 2002

1 reference

Europe PubMed Central

23 November 2017

American Journal of Respiratory and Critical Care Medicine

1 reference

Europe PubMed Central

23 November 2017

165

1 reference

Europe PubMed Central

23 November 2017

10

1 reference

Europe PubMed Central

23 November 2017

1433-1438

1 reference

Europe PubMed Central

23 November 2017

From the National Institute of Allergy and Infectious Diseases and the World Health Organization. Respiratory syncytial and parainfluenza viruses

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Risk of primary infection and reinfection with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Respiratory syncytial virus and parainfluenza virus

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Bronchiolitis-associated hospitalizations among US children, 1980-1996.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Therapy for respiratory tract infections caused by respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Properties of the novel proinflammatory supergene "intercrine" cytokine family.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Multiple cis regulatory elements control RANTES promoter activity in alveolar epithelial cells infected with respiratory syncytial virus.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-kappa B and NF-IL-6.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. The LiquiVent Study Group

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Perfluorocarbon-associated gas exchange improves oxygenation, lung mechanics, and survival in a model of adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Partial liquid ventilation decreases the inflammatory response in the alveolar environment of trauma patients.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Primary respiratory syncytial virus infection in mice

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Role of NFkappaB in the mortality of sepsis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Cytokines and chemokines in respiratory secretion and severity of disease in infants with respiratory syncytial virus (RSV) infection

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Tissue perfusion and oxygenation with blood substitutes

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Liquid ventilation in the preterm neonate

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Perfluorochemical-based artificial oxygen carrying red cell substitutes

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Intratracheal administration of perfluorochemical-gentamicin suspension: a comparison to intravenous administration in normal and injured lungs

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Perfluorohexane attenuates proinflammatory and procoagulatory response of activated monocytes and alveolar macrophages

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Perflubron decreases inflammatory cytokine production by human alveolar macrophages.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Perfluorocarbon blocks tumor necrosis factor-alpha-induced interleukin-8 release from alveolar epithelial cells in vitro

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Growth and serological characteristics of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Immune-mediated disease pathogenesis in respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-kappa B and is inhibited by sodium salicylate and aspirin

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Synergistic upregulation of interleukin-8 secretion from pulmonary epithelial cells by direct and monocyte-dependent effects of respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Partial Liquid Ventilation in Adult Patients With ARDS

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2109077

21 January 2018

Identifiers

10.1164/RCCM.2109077

1 reference

Europe PubMed Central

23 November 2017

1 reference

Europe PubMed Central

23 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43420485&oldid=1988443160"